NCT07302776 2025-12-24TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTStanford UniversityPhase 1 Not yet recruiting50 enrolled
NCT02960646 2023-02-16Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesM.D. Anderson Cancer CenterPhase 1 Completed11 enrolled
NCT00589316 2023-02-09Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic SyndromeFred Hutchinson Cancer CenterPhase 1 Terminated26 enrolled 21 charts
NCT00513474 2017-05-25Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantMassachusetts General HospitalPhase 1 Completed46 enrolled 11 charts
NCT00104975 2016-12-15Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerYale UniversityPhase 1 Completed20 enrolled